v3.26.1
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 862 $ 24,138 $ (59,655) $ (34,655)
Balance (in Shares) at Dec. 31, 2025 8,625,000 [1]      
Accretion for Class A ordinary shares to redemption amount (9,869,503) (13,578,604) (23,448,107)
Sale of 4,666,666 Private Placement Warrants 7,000,000 7,000,000
Fair Value of Public Warrants at issuance 3,076,250 3,076,250
Allocated value of transaction costs to Class A shares (230,885) (230,885)
Net loss (2,946,856) (2,946,856)
Balance at Mar. 31, 2026 $ 862 (16,585,115) (16,584,253)
Balance (in Shares) at Mar. 31, 2026 8,625,000 [1]      
Balance at Dec. 31, 2025 $ 862 24,138 (59,655) (34,655)
Balance (in Shares) at Dec. 31, 2025 8,625,000 [1]      
Net loss         (1,057,842)
Balance at Jun. 30, 2026 $ 862 (17,346,182) (17,345,320)
Balance (in Shares) at Jun. 30, 2026 8,625,000      
Balance at Mar. 31, 2026 $ 862 (16,585,115) (16,584,253)
Balance (in Shares) at Mar. 31, 2026 8,625,000 [1]      
Accretion for Class A ordinary shares to redemption amount (2,650,081) (2,650,081)
Net loss 1,889,014 1,889,014
Balance at Jun. 30, 2026 $ 862 $ (17,346,182) $ (17,345,320)
Balance (in Shares) at Jun. 30, 2026 8,625,000      
[1] Includes an aggregate of up to 1,125,000 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On February 13, 2026, the Company consummated its Initial Public Offering and sold 28,750,000 Units, including 3,750,000 Units sold pursuant to the full exercise of the underwriters’ over-allotment option, as a result the 1,125,000 Class B ordinary shares are no longer subject to forfeiture.